The mice transplanted with the Rcor2-knockdown B7-H4-null AML cells developed leukemia much more slowly than that of mice transplanted with B7-H4-null leukemia cells, which was comparable to their WT counterparts (Figure 1c, third panel and Supplementary Figure 4d). Here, RCOR2 is linked to acute myeloid leukemia.